DBSR

Though research on age differences has its place, almost by definition, research on aging involves tracking people over time periods long enough to observe long-term changes in their lives and health. And, accurate measurements of large samples can be an expensive undertaking. The NIA has made major investments to create and maintain data resources that can be used for dozens—and in some cases, hundreds—of analyses, using the tools of the behavioral and social sciences.

ShareThis: 

NIH-supported trials of testosterone therapy in older men report mixed results

In older men with low testosterone, one year of testosterone treatment improved bone density and corrected anemia of both known and unknown causes, but also increased the volume of coronary artery plaque, according to results reported from the Testosterone Trials (T Trials). Testosterone treatment had no effect on memory or other cognitive function. The results are reported in two journals coming out this week.

Flip a coin? Roll the dice? Consult an expert? How do you decide?

What happens as we age that may either compromise or strengthen our decision-making capacities? To appreciate how aging affects our ability to make decisions, we need to first understand age-related changes in basic psychological processes involved, including social, cognitive and emotional motivations for decisions. Research providing that knowledge can help us build better interventions to support decision making by older adults including decisions that affect their health.

Tag: 
ShareThis: 

The entire U.S. government, including NIA, is currently operating under an extension of a continuing resolution (CR) that will end on April 28…unless it is extended again, that is. A continuing resolution extends the previous year’s appropriations act, and the appropriations language within it, into the next fiscal year. It is usually minimally altered from the terms in the prior year. In other words, at this point in FY 2017, we’re operating with virtually the same budget we had in FY 2016.

ShareThis: 

Researchers often complain to us that new funding opportunity announcements (FOAs) scoot past them, lost in the blizzard of information that arrives daily. Unless you obsessively monitor the NIH Guide—which we’re not necessarily recommending—you may not see every new announcement that NIA publishes. And, unless you have a well-thought-out research proposal outlined and ready to commit to paper, it sometimes can be difficult to pull together a grant application in the time allowed.

ShareThis: 

Small smiles of satisfaction spread around the staff in my office last week. The NIH Guide published the last of our long-running saga of funding opportunity announcements (FOAs) on Alzheimer’s disease and Alzheimer’s-related dementias (ADRD). These were the concepts that the National Advisory Council on Aging approved last September (Thank you again, everyone!).

ShareThis: 

We are excited to let you know that NIA has a resource for investigators seeking to analyze biomedical data. The Health, Aging and Body Composition (Health ABC) Study began in 1997 and collected data for 17 years on a cohort of older black and white adults living in Memphis and Pittsburgh. Participants were aged 70-79 at baseline. These data are now online on NIA’s website and available to qualified researchers. We invite you to take a look!

ShareThis: 

The mighty push for research on Alzheimer’s disease and related dementias continues at NIA. While an earlier blog highlighted the research initiatives we have published, this chapter covers the more recent publication of two training initiatives and four small business-related initiatives.

ShareThis: 

National study reports decreased dementia prevalence

Dementia prevalence among Americans age 65 and older decreased significantly between 2000 and 2012, according to a study published in JAMA Internal Medicine on November 21, 2016. Results from the nationally representative Health and Retirement Study (HRS) found that dementia prevalence decreased from 11.6 percent in 2000 to 8.8 percent in 2012, representing a relative decrease of about 24 percent.

I visited Cleveland over Thanksgiving. In a moment of peace from family conversations, I picked up the local paper. The first story I encountered was a long report on the Health and Retirement Study findings, funded by NIA, showing a substantial decline in U.S. dementia rates in the last 20 years. Then, I encountered a story reporting Eli Lilly’s negative clinical trial results on solanezumab. My immediate conclusion was that, no matter where I go, my job follows me!

ShareThis: 
Subscribe to RSS - DBSR